REAL-WORLD OUTCOMES WITH MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA ACCORDING TO SMOKING HISTORY AND COPD STATUS AT ENROLLMENT: REALITI-A POST HOC ANALYSIS

被引：0
|
作者：
Bagnasco, Diego
Hill, David G.
Welte, Tobias
Chaudhuri, Rekha
Price, Robert
Howarth, Peter
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.102
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：75A / 76A
页数：2
相关论文
共 50 条
  • [21] HEALTHCARE RESOURCE USE IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA AFTER THE INITIATION OF MEPOLIZUMAB IN REAL-LIFE SETTINGS - REALITI-A STUDY
    Yang, S.
    Maxwell, A.
    Joksaite, S.
    Chaudhuri, R.
    Pastorello, E. A.
    Lee, J.
    Kohler, T. C.
    Ramos-Barbon, D.
    Schleich, F.
    Steven, G.
    Alfonso, R.
    VALUE IN HEALTH, 2020, 23 : S361 - S361
  • [22] How Real-World Mepolizumab Users in the REALITI-A Study Relate to the Recruitment Criteria Applied in the Randomized, Placebo-Controlled Trials of Subcutaneous Mepolizumab in Severe Eosinophilic Asthma
    Ramos-Barbon, D.
    Bals, R.
    Crimi, N.
    Menzies, D.
    Pek, B.
    Pilette, C.
    Steven, G.
    Alfonso-Cristancho, R.
    Jakes, R.
    Maxwell, A. C.
    Price, R. G.
    Yang, S.
    Howarth, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [23] UK severe asthma patient outcomes in the real-world versus Italy and the USA: REALITI-A at 2 years
    Weir, J.
    Egan, B.
    Heaney, L.
    Menzies, D.
    Pfeffer, P.
    Howarth, P.
    Chaudhuri, R.
    THORAX, 2023, 78 (SUPPL_4) : A184 - A184
  • [24] Mepolizumab Provides Real-World Clinical Benefits in Severe Eosinophilic Asthma Irrespective of Baseline Lung Function: Results From the REALITI-A Study at 2 Years
    Bagnasco, D.
    Pilette, C.
    Lougheed, M.
    Caruso, C.
    Echave-Sustaeta, J.
    Dennison, P.
    Verghis, R.
    Jakes, R.
    Rais, M.
    Howarth, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [25] Real-world safety of treatment with mepolizumab and reslizumab in patients with severe eosinophilic asthma
    Ordonez Pinilla, Karen A.
    Moya Camacho, Beatriz
    Fernandez Rodriguez, Consuelo
    Fernandez Crespo, Jesus F.
    Garcia Moguel, Ismael
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB99 - AB99
  • [26] Efficacy and Safety of Mepolizumab in a Real-World Cohort of Patients with Severe Eosinophilic Asthma
    Pertzov, B.
    Unterman, A.
    Shtraichman, O.
    Shitenberg, D.
    Rosengarten, D.
    Kramer, M. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [27] Efficacy and safety of mepolizumab in a real-world cohort of patients with severe eosinophilic asthma
    Pertzov, Barak
    Avraham, Unterman
    Osnat, Shtraichman
    Dorit, Shitenberg
    Dror, Rosengarten
    Reuven, Kramer Mordechai
    JOURNAL OF ASTHMA, 2021, 58 (01) : 79 - 84
  • [28] Real-world experience of mepolizumab in severe eosinophilic asthma - five-year outcomes
    Nuttall, Amy
    Fyles, Fred
    Joplin, Hannah
    Burhan, Hassan
    Watkins, Laura
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [29] Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study
    Chapman, Kenneth R.
    Cogger, Kathryn
    Arthurs, Erin
    LaForty, Callahan
    Golden, Shane
    Millson, Bradley
    Usuba, Koyo
    Licskai, Christopher
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2024, 20 (01):
  • [30] Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study
    Kenneth R. Chapman
    Kathryn Cogger
    Erin Arthurs
    Callahan LaForty
    Shane Golden
    Bradley Millson
    Koyo Usuba
    Christopher Licskai
    Allergy, Asthma & Clinical Immunology, 20
12345